EDIT vs GD
Editas Medicine Inc (EDIT) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
EDIT currently screens at market cap $375.2M. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the EDIT and GD stock pages for the full models.
Not investment advice.